Two Miller School Faculty Members Inducted into Association of American Physicians
Two University of Miami Miller School of Medicine physicians have been inducted into the prestigious Association of American Physicians (AAP), founded in 1885 for “the advancement of scientific and practical medicine.” Induction is considered a great honor as members have included Nobel laureates and members of the National Academy of Science and the Institute of Medicine.
The new UM honorees are Margaret Fischl, M.D., professor of medicine, director of the AIDS Clinical Research Unit and co-director of the Miami Center for AIDS Research, and Joshua Hare, M.D., Louis Lemberg Professor of Medicine and director of the Interdisciplinary Stem Cell Institute. They were inducted during the organization’s annual meeting in Chicago on April 17.
“We are so proud to have two of our faculty members inducted into the AAP as a testament to their great scientific, clinical and other academic accomplishments,” said Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School and CEO of UHealth – University of Miami Health System. “Drs. Fischl and Hare are stellar physician-scientists who have made seminal contributions to advancing science in their chosen fields. Both of them are exceptional pioneers.”
Dr. Fischl has been a pioneer in anti-retroviral research and has led numerous studies dealing with HIV/AIDS and Kaposi’s sarcoma, including the first studies evaluating zidovudine (AZT), combination drug regimens and lower doses of nucleoside analogues for toxicity for HIV-infected patients. She also served as senior author of a study published in The New England Journal of Medicine, which proved the effectiveness of triple combination drug therapy using the newest class of anti-retroviral drugs called protease inhibitors. Additionally, Dr. Fischl was the first physician to demonstrate that use of trimethoprim-sulfamethoxozole in the prevention of HIV-related pneumocystis carinii pneumonia improved survival rates. Her research continues to focus on novel treatment approaches including the assessment of a new retrovirus-based vaccine.
“It is truly an honor to be elected to the American Association of Physicians,” said Dr. Fischl. “It has been an extraordinary privilege to have been in the forefront of HIV research with so many exceptional colleagues. Defining lifesaving treatment for HIV infection and to now focus on pathways to a cure speaks to the remarkable effort and work in this area of research.”
Dr. Hare has made major contributions to mechanistic, translational, and clinical research in the field of heart failure and left ventricular dysfunction. He is considered one of the leading clinician-scientists advancing stem cell therapy for heart disease. Dr. Hare is best known for his seminal work in translating stem cell research to early observations in human populations, showing that bone marrow mesenchymal stem cells can heal injured hearts in clinically meaningful ways. Dr. Hare founded the Miller School’s Interdisciplinary Stem Cell Institute in 2008. The institute has grown to exceed 50 faculty members working across 15 departments, tackling the new and exciting area of regenerative medicine at the basic and clinical levels.
“I am so honored to be recognized by election to the American Association of Physicians,” said Dr. Hare. “I am grateful for the opportunities I have had to conduct research designed to help people with chronic incurable diseases. The fact that my team’s research could lead to a new treatment paradigm that uses stem cells as a viable option for so many diseases is wonderfully gratifying.”